Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RAPID MICRO BIOSYSTEMS, INC. Director's Dealing 2025

Oct 21, 2025

33936_dirs_2025-10-21_20106c91-9da5-48f2-9138-6e0af921c921.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK: 0001380106
Period of Report: 2025-10-17

Reporting Person: Spignesi Robert G. Jr. (Director, PRESIDENT AND CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-10-17 Class A Common Stock M 3400 $0.75 Acquired 973950 Direct
2025-10-17 Class A Common Stock F 2072 $3.08 Disposed 971878 Direct
2025-10-17 Class A Common Stock M 7833 $0.75 Acquired 979711 Direct
2025-10-17 Class A Common Stock F 4774 $3.08 Disposed 974937 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-10-17 Stock Option (Right to Buy) $0.75 M 3400 Disposed 2025-10-22 Class A Common Stock (3400) Direct
2025-10-17 Stock Option (Right to Buy) $0.75 M 7833 Disposed 2025-10-22 Class A Common Stock (7833) Direct

Footnotes

F1: Represents a "net exercise" of outstanding stock options. The reporting person received 1,328 shares of common stock on net exercise of option to purchase 3,400 shares of common stock. The Company withheld 2,072 shares of common stock underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on October 17, 2025 of $3.08, pursuant to the terms of the 2010 Stock Option and Grant Plan.

F2: Represents a "net exercise" of outstanding stock options. The reporting person received 3,059 shares of common stock on net exercise of option to purchase 7,833 shares of common stock. The Company withheld 4,774 shares of common stock underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on October 17, 2025 of $3.08, pursuant to the terms of the 2010 Stock Option and Grant Plan.

F3: The option is fully vested and exercisable.